According to the European Patent Office, there will be no patents in Europe for embryonic stem cells. The board decided to fully uphold a sentence from June by a select committee regarding a request for a patent made by the Wisconsin Alumni Research Foundation, based at the University where James Thompson, the scientist who discovered stem cells, works. “European patent law prohibits the application of patents to stem cell cultures whose preparation necessarily implicates the destruction of human embryos.”
An exercise machine that helps stroke victims walk. An advanced technology for assessing the progress of prostate cancer. A faster process for making neural stem cells to investigate new treatments for injury and disease. A cheaper, more beautiful LED light bulb. A game to teach meditation.
These projects, and a dozen more, are beneficiaries of the first round of awards by the University of Wisconsin-Madison’s Discovery to Product, or D2P, program, which began operating in March. The 17 grants announced this week will support innovations in many fields of research at the university, from food engineering and medicine to stem